Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (9808)	10/21/1997 1:12:00 AM
From: Andrew H	Read Replies (1) \| Respond to of 32384

>>What most posters fail to understand is the importance of this agreement to LLY. They are using LGND's technnology to move their research into the next mellinium. LGND will harness an extraordinary share of LLY's R&D budget for developing potent oral treaments for several metabolic diseases, including but certainly not limited to diabetes. It was NOT a coincidence that LGND and LLY were on CNBC today, nor was it a coincidence that the deal was announced on the same day as LLY's earnings.<< If such is the case, we should get a couple of new brokerage coverages and recommendations before too long.

To: Henry Niman who wrote (9808)	10/21/1997 11:15:00 AM
From: chirodoc	Read Replies (2) \| Respond to of 32384

<<<<<What most posters fail to understand is the importance of this agreement to LLY. They are using LGND's technnology to move their research into the next mellinium. LGND will harness an extraordinary share of LLY's R&D budget for developing potent oral treaments for several metabolic diseases, including but certainly not limited to diabetes. .......how true......when analysts are bending over backward and pounding the table to BUY LILLY......this imho, as you so eloquently stated, will make other big pharmas take a long hard look at ligand........this will bring in lots more cash......and if ligand has good management........a strong elevation in stock price.